Glenn Steele Jr. M.D. Ph.D., Director at PTC THERAPEUTICS, INC. (PTCT), sold 12,000 shares at $65.16 ($782K) on 2026-09-30, disclosed to the SEC on 2026-10-02.
Scheduled sale ($782k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |